A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
Clinical trial NCT04861259 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04861259
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-22
- Primary completion
- 2025-10-09
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.